The Latest Breaking News from European Union

Biopharmaceutical giant Gilead Sciences’ (GILD) shares have risen nearly 30% over the past year despite lingering macroeconomic challenges. Moreover, the company delivered solid growth last year and is expected to maintain its business momentum in 2023 and beyond, driven by its diversified medicines portfolio. Hence, investors could consider buying and…

A lot of the changes coming in throughout the rest of the year may affect your personal finances and daily life

‘That’s just Boris being Boris,’ the former UKIP leader says

The return of Boris Johnson, Matt Hancock and Partygate shows that, as the Godfather found, it’s almost impossible to escape past sins, says Guardian columnist Jonathan Freedland

Despite macroeconomic uncertainties, the biotech industry is anticipated to thrive amid robust demand and lucrative government initiatives. Given the promising prospects of the industry, quality stocks Gilead Sciences (GILD), Incyte (INCY), and Taisho Pharmaceutical (TAIPY) might be wise additions to your portfolio. These stocks are currently trading under $100. Keep…

Many countries are struggling with worker shortages right now as companies in the US, UK and the EU all struggle to fill job vacancies.

It could place restrictions on cables that don’t meet its Made for iPhone certification standards.

Tensions continue to mount between Russia and Moldova – a small country bordering on southwestern Ukraine that is seeking European Union membership. Moldova is also home to a breakaway region called Transnistria that has strong Russian ties, landing both places in the crosshairs of the war in Ukraine.

Russia’s war in Ukraine has quickly refocused the politics of its Baltic neighbours. Renewed threats to national security have swiftly risen to the top of each nation’s priorities.